Regencell Bioscience Holdings Ltd
RGC
Get informed when a big investor buys or sells
+ FollowCurrent Fair Value
100% downsideOvervalued by 100% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.82 Billion |
|---|---|
| Enterprise Value | $11.82 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | 1.85 |
| Outstanding Shares | 494,488,908 |
Return
| Return on Equity | -913.36% |
|---|---|
| Return on Assets | -369.60% |
| Return on Invested Capital | -842.23% |
Valuation & Multiples
| P/E Ratio | -1676.69 |
|---|---|
| PEG | -897.11 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1041.13 |
| Enterprise Value to Net Income | -1061 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.32 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.7720▼ 23.06% |
|---|---|
| Total Calls | 60,100▲ 60.27% |
| Total Puts | 106,500▲ 41.81% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.13%▲ 0.02% |
|---|---|
| Total Invested | $16.46M▲ 42.92% |
| Investors Holding | 37▲ 16.00% |
ESG Score
No data
About Regencell Bioscience Holdings Ltd
Relevant Senate Committees
Provides crucial analysis and scoring for all tax legislation, directly influencing corporate tax rates, R&D credits, and other fiscal policies that impact the financial health and investment decisions of manufacturing companies like Regencell Bioscience.
Controls tax policy, which directly affects corporate profitability and investment decisions for all companies, including Regencell Bioscience. It also influences entitlement spending (like Medicare), which is critical for the pricing and reimbursement of medicinal products.
Oversees the FDA (Food and Drug Administration), which is the primary regulatory body for medicinal products, including botanical medicines. This committee directly influences product approval processes, labeling, and safety standards, critically impacting Regencell's operations and market access.